This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Apr;75(4):e101-e102.

doi: 10.1016/j.eururo.2018.11.034. Epub 2018 Nov 30.

Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410-8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?

Liselotte M S Boevé¹, André N Vis²

Affiliations

Affiliations

¹ Department of Urology, OLVG, Amsterdam, The Netherlands; Department of Urology, UMC Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands. Electronic address: l.boeve@olvg.nl.
² Department of Urology, UMC Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.

PMID: 30503181
DOI: 10.1016/j.eururo.2018.11.034

Comment

Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410-8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?

Liselotte M S Boevé et al. Eur Urol. 2019 Apr.

. 2019 Apr;75(4):e101-e102.

doi: 10.1016/j.eururo.2018.11.034. Epub 2018 Nov 30.

Authors

Liselotte M S Boevé¹, André N Vis²

Affiliations

¹ Department of Urology, OLVG, Amsterdam, The Netherlands; Department of Urology, UMC Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands. Electronic address: l.boeve@olvg.nl.
² Department of Urology, UMC Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.

PMID: 30503181
DOI: 10.1016/j.eururo.2018.11.034

No abstract available

PubMed Disclaimer

Comment on

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.
Boevé LMS, Hulshof MCCM, Vis AN, Zwinderman AH, Twisk JWR, Witjes WPJ, Delaere KPJ, Moorselaar RJAV, Verhagen PCMS, van Andel G. Boevé LMS, et al. Eur Urol. 2019 Mar;75(3):410-418. doi: 10.1016/j.eururo.2018.09.008. Epub 2018 Sep 25. Eur Urol. 2019. PMID: 30266309 Clinical Trial.
Re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: High-volume Disease Has a Different Standard of Care.
García-Perdomo HA. García-Perdomo HA. Eur Urol. 2019 Apr;75(4):e100. doi: 10.1016/j.eururo.2018.11.030. Epub 2018 Nov 23. Eur Urol. 2019. PMID: 30477982 No abstract available.

Similar articles

Re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: High-volume Disease Has a Different Standard of Care.
García-Perdomo HA. García-Perdomo HA. Eur Urol. 2019 Apr;75(4):e100. doi: 10.1016/j.eururo.2018.11.030. Epub 2018 Nov 23. Eur Urol. 2019. PMID: 30477982 No abstract available.
Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8.
Vis AN, Boevé LMS. Vis AN, et al. Eur Urol. 2019 May;75(5):e131-e132. doi: 10.1016/j.eururo.2018.12.024. Epub 2019 Jan 4. Eur Urol. 2019. PMID: 30616950 No abstract available.
Re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial.
Shinde A, Li R, Amini A, Glaser S. Shinde A, et al. Eur Urol. 2019 Mar;75(3):e69-e70. doi: 10.1016/j.eururo.2018.11.008. Epub 2018 Nov 18. Eur Urol. 2019. PMID: 30463663 No abstract available.
The timing and extent of androgen deprivation therapy for prostate cancer: weighing the clinical evidence.
Ginzburg S, Albertsen PC. Ginzburg S, et al. Endocrinol Metab Clin North Am. 2011 Sep;40(3):615-23, ix. doi: 10.1016/j.ecl.2011.05.005. Epub 2011 Jul 7. Endocrinol Metab Clin North Am. 2011. PMID: 21889724 Review.
External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.
Koontz BF, Lee WR. Koontz BF, et al. Arch Esp Urol. 2011 Oct;64(8):858-64. Arch Esp Urol. 2011. PMID: 22052767 Review. English, Spanish.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information